A novel method for objective vision testing in canine models of inherited retinal disease

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 8, 2008, Pages 3568-3576

  Gearhart, Patricia M ^a   Gearhart, Chris C ^a   Petersen Jones, Simon M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE; EYE PROTEIN; PROTEIN SUBUNIT; CARRIER PROTEIN; PHOSPHODIESTERASE 6;

ACCURACY; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRIGHTNESS; CONTROLLED STUDY; DISEASE MODEL; DOG; FEMALE; FUNCTIONAL ASSESSMENT; GENE MUTATION; GENETIC DISORDER; LIGHT INTENSITY; MALE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DETERMINATION; RED LIGHT; RETINA DISEASE; SENSITIVITY ANALYSIS; TASK PERFORMANCE; VISION TEST; ANIMAL; ANIMAL BEHAVIOR; ANIMAL DISEASE; DECISION MAKING; DOG DISEASE; ELECTRORETINOGRAPHY; GENETICS; LABORATORY DIAGNOSIS; LIGHT; MUTATION; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; RETINA; RETINA DEGENERATION; SENSITIVITY AND SPECIFICITY; VISUAL ACUITY;

ANIMALS; BEHAVIOR, ANIMAL; CARRIER PROTEINS; CHOICE BEHAVIOR; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 6; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; ELECTRORETINOGRAPHY; EYE PROTEINS; FALSE POSITIVE REACTIONS; FEMALE; LIGHT; MALE; MUTATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL DEGENERATION; SENSITIVITY AND SPECIFICITY; VISION TESTS; VISUAL ACUITY;

EID: 49049088963     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0625     Document Type: Article

References (26)

1. Petersen-Jones S. Advances in the molecular understanding of canine retinal diseases. J Small Anim Pract. 2005;46:371-380.
2. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
3. Narfström K, Katz ML, Bragadottir R, et al. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci. 2003;44:1663-1672.
4. Ford M, Bragadottir R, Rakoczy PE, Narfström K. Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results. Doc Ophthalmol. 2003;107:79-86.
5. LeMeur G, Stieger K, Smith AJ, et al. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther. 2007;14:292-303.
6. Jacobs JB, Dell'Osso LF, Hertle RW, Acland GM, Bennett J. Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system. Invest Ophthalmol Vis Sci. 2006;47:2865-2875.
7. Prusky GT, West PW, Douglas RM. Behavioral assessment of visual acuity in mice and rats. Vision Res. 2000;40:2201-2209.
8. Prusky GT, West PW, Douglas RM. Reduced visual acuity impairs place but not cued learning in the Morris water task. Behav Brain Res. 2000;116:135-140.
9. Thomas BB, Seiler MJ, Sadda SR, Coffey PJ, Aramant RB. Optokinetic test to evaluate visual acuity of each eye independently. J Neurosci Methods. 2004;138:7-13.
10. Montiani-Ferreira F, Li T, Kiupel M, et al. Clinical features of the retinopathy, globe enlarged (rge) chick phenotype. Vision Res. 2003;43:2009-2018.
11. Talbott RE. Postural reactions of dogs to sinusoidal motion in the peripheral visual field. Am J Physiol. 1980;239:R71-R79.
12. Karn HW, Munn NL. Visual pattern discrimination in the dog. Pedagog Semin J Genet Psychol. 1932;40:363-374.
13. Geisbauer G, Griebel U, Schmid A, Timney B. Brightness discrimination and neutral point testing in the horse. Can J Zool. 2004;82:660-670.
14. Hall CA, Cassaday HJ, Derrington AM. The effect of stimulus height on visual discrimination in horses. J Anim Sci. 2003;81:1715-1720.
15. Neitz J, Geist T, Jacobs GH. Color-vision in the dog. Vis Neurosci. 1989;3:119-125.
16. de Rivera C, Boutet I, Zicker SC, Milgram NW. A novel method for assessing contrast sensitivity in the beagle dog is sensitive to age and an antioxidant enriched food. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:379-387.
17. Milgram NW, Head E, Weiner E, Thomas E. Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks. Behav Neurosci. 1994;108:57-68.
18. Veske A, Nilsson SE, Narfström K, Gal A. Retinal dystrophy of swedish Briard/Briard-beagle dogs is due to a 4-bp deletion in RPE65. Genomics. 1999;57:57-61.
19. Petersen-Jones SM, Entz DD, Sargan DR. cGMP phosphodiesterase-α mutation causes progressive retinal atrophy in the Cardigan Welsh corgi dog. Invest Ophthalmol Vis Sci. 1999;40:1637-1644.
20. Redmond TM, Yu S, Lee E, et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20:344-351.
21. Wenzel A, von Lintag J, Oberhauser V, Tanimoto N, Grimm C, Seeliger MW. RPE65 is essential for the function of cone photoreceptors in NRL-deficient mice. Invest Ophthalmol Vis Sci. 2007;48:534-542.
22. Seeliger MW, Grimm C, Stahlberg F, et al. New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet. 2001;29:70-74.
23. Narfström K, Wrigstad A, Nilsson SEG. The briard dog: a new animal model of congenital stationary night blindness. Br J Ophthalmol. 1989;73:750-756.
24. Nilsson SE, Wrigstad A, Narfström K. Changes in the DC electroretinogram in Briard dogs with hereditary congenital night blindness and partial day blindness. Exp Eye Res. 1992;54:291-296.
25. Thompson DA, Gyurus P, Fleischer LL, et al. Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2000;41:4293-4299.
26. Pang JJ, Chang B, Kumar A, et al. Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Mol Ther. 2006;13:565-572.